Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-06

Clinical Trial Update: Efficacy of Doxycycline Prophylaxis to Reduce Syphilis in High-Risk, HIV-Positive MSM [NA]

View source ↗

Summary

This completed clinical trial evaluated whether doxycycline prophylaxis reduces syphilis incidence in high-risk HIV-positive men who have sex with men.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)

Snippet

Sponsor: Los Angeles LGBT Center | Conditions: Syphilis | NA | Status: COMPLETED